Bliley TI
[Memorandum Regarding Congressional Hearings and Investigations of Nicotine and Cigarettes]
Abstract
Transmits transcripts and related documents from Congressional Hearings on whether nicotine is a drug and whether industry is adding nicotine to cigarettes. Names principal figures and government agencies involved in investigation along with television networks that contacted Tobacco Institute (TI) for comments. Documents industry briefing of "23 Members from the tobacco-producing states on questions raised by recent media coverage on tobacco issues." Relates TI and Covington & Burling collaboration "to prepare [TI] testimony and expert witnesses" for upcoming hearing on H.R. 2147, a bill by Rep. Michael Synar to create new regulatory authority over tobacco" in the Food and Drug Administration (FDA). Identifies areas of concern for which potential witnesses will be contacted (attachments missing).
Fields
- Company
- Tobacco Institute
- Type
- Memorandum
- Named Organization
- ABC
- Assistant Secretary for Health
- Associated Press
- CBS
- Centers for Disease Control
- CNBC
- Congress
- Covington & Burling (Tobacco Industry law firm)Tobacco industry law firm. Was involved in organizing the Whitecoat Project.
- Department of Health and Human Services
- Department of Justice
- FDA
- Food and Drug Administration
- HHS
- House
- House Appropriations Subcommittee on Agriculture, Rural Development, Food & Drug Administration and Related Agencies
- House Energy & Commerce Subcommittee on Health & the Environment
- Lorillard Inc. (American cigarette manufacturer)American cigarette manufacturer
- NBC
- Keyword
- First Amendment
- H.R. 2147
- Hearings
- Tobacco-producing states
- Wire story
- Witnesses
- Named Person
- Whitley, C.O.
- Durbin, R. Rep.
- Kessler, David A. Commissioner
- Lee, P.R. MD
- Spears, A.W. Dr.
- Synar, M. Rep.
- Waxman, H. Rep.
- Copied
- Tobacco Institute Senior Staff
- Members of the Management Committee
- Recipient
- Members of the Executive Committee
- Author
- Chilcote, Samuel D., Jr. (TI President (1981-1997))Chilcote has knowledge of The Tobacco Institute's and the tobacco industry's participation in public fraud and disinformation relative to health hazards of tobacco use, in the manipulation of nicotine in tobacco products and in marketing of tobacco products to children.
- Subject
- Additives
- Cigarettes
- Federal level
- Government agencies
- Legislatures
- mass media
- nicotine
- Regulations
- Research studies
- State level
- testimony
- tobacco industry structure
- Warning labels
- addiction
Document Images
CONFIDENTIAL: '~ " "
MINNESOTA TOBACCO LITIGATION"
THE TOBACCO INSTITUTE
I~. 1875 1 STREET, NORTHWEST
SAMUEL D. CHILCOTE, JR.
"~/~/~ ~. WASHINGTON, DC 20008
President
To: The M:~ers of ~he Exeeueive Co~ittee .
From: S~ue L D. Chiloote, Jr.~
This morning, ~le House Appropriations Subcommittee on
Agriculture, R~al Development, Food & Drug Administration (FDA)
and Related Agencies held a hearing on Fiscal Year 1995
appropriations ~or the FDA. Although FDA Commissioner David A.
Kessler's prepared testimony did not deal with tobacco issues,
Subcommittee Chairman Richard Durbin engaged Kessler in a lengthy
discussion of p~tential regulation of tobacco by .FDA. Philip R.
Lea, M.D., assistant secretary for health in the Department of
Health & Human ~ervices (HHS), also participated in this
discussion~ A ~ranscript from this part of the hearing is
enclosed.
The question-an~-answer session touched on FDA's ongoing analysis
Of "whether the nicotine in the cigarette is a drug" and on the
review of cigaratte ingredients conducted at HHS. Dr. Lee noteO
that HHS had recently "referred to the Department of Justice
inforNation that we asked them to investigate regarding the
possibility thaC the tobacco companies were in fact adding
nicotine to cigarettes." Dr. Lee also stated that the Centers
for Disease Control is preparing a report to Congress on
cigarette ingredients, which will be submitted to his office "i~
the very near future."
The major television networks have contacted TheInstitute for
comment on the Department of Justice investigation. TI
spokespersons bare provided interviews thus far to ABC, CBS, NBC
and CNBC. The Associated Press also is running a wire story on
this issue.
Today, Lorilla~d Vice President and Chief Operating Officer Dr.
Alexander W. S~ears, Tobacco Institute consultant and former
Member of Congl'ess Charles O. Whitley, and I briefed 23 Members
from the tobacco-producing states on questions raised by recent
media coverage on tobacco issues. Further details are provided "-
by separate me~randum.
CONFIDENTIAL:
MINNESOTA TOBACCO LITIGATION
The Members of ~e Executive Committee
M~h 16, 1994
Page Two PRIVILEGED AND cONFIDENTIAL
l, xot~xt ,~-- "--ee~ as ~eauired_~ by the Coufl's Maxch 7,1998 O~de~ in
State oi Minnesota, et aL v. Philip Morals, et at.
CoU~ File No.: C1.94-8.565
~nina.lly, TI sta.~f are working with Covington & Burling.to prepare
stltute test_~.aony and expert witnesses for the upcomlng hearing
on H.R. 2147, a bill by Rep. Michael Synar to create new
regulatory auth.}rity over tobacco in the FDA.3 This hearing is
tentatively sch:~.duled for March 25 in the House Energy & Commerce
Subcommittee on Health & the Environment, chaired by Rep. Henry
Waxman.
Potential witne:sses are being contacted to address First
Amendment conce ms, the workings of the FDA, "warning" labels,
"addiction" claims, nicotine, and ingredients. Your cooperation
in identifying ,Ind providing these witnesses is very helpful.
We will send fu1.'ther information on the March 25 hearing and
other dev.elopme-.~ts as it becomes available.
SDC: cjy
Enclosure
cc: The Member3 of the Management Committee
TI Senior ~taff
TIMN 0046937
